Biostar pharmaceuticals, inc. (BSPM)
Income statement / Yearly
Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Sales, net

2,384

27,129

61,416

52,729

49,317

91,965

Cost of sales

1,469

16,025

31,140

27,046

19,466

27,578

Gross profit

915

11,104

30,276

25,682

29,851

64,387

Advertising expenses

0

3,803

8,594

7,562

14,154

21,234

Selling expenses

1,169

4,835

9,892

9,012

13,734

16,992

General and administrative expenses

2,431

4,648

7,718

6,092

5,951

5,676

Impairment loss on intangible assets

0

2,973

990

240

-

-

Provision for doubtful debt

-265

4,666

0

-1,291

3,674

0

Compensation paid to customers - note 14)

-

-

-

-

8,044

0

Administrative penalty - note 14)

-

-

-

-

1,601

0

Research and development expenses

1,144

4,020

2,766

3,228

4,475

2,323

Impairment loss on loan receivables

0

8,845

0

330

-

-

Impairment loss on prepaid lease payment

0

1,066

0

0

-

-

Construction in progress written off

-

-

1,627

-

-

-

Impairment loss on other receivable

-

-

-

-

0

-

Gain from bargain purchase

-

-

-

-

-

1,299

Impairment loss on intangible assets

-

-

-

-

0

1,784

Total operating expenses

4,479

34,861

31,589

25,174

51,637

46,228

Loss from operations

-3,564

-23,757

-1,312

508

-21,786

18,159

Interest income

1

8

1,330

1,344

296

430

Interest expense

206

283

154

367

84

41

Fair value adjustment on warrants

227

324

577

0

-

-

Other income

-

-

-

2

-

-

Gain on disposal of intangible assets

-

-

0

1,168

0

-

Other income

-

-

1,093

0

0

0

Other income (expense), net

496

-84

0

-

-

-

Foreign exchange gain

-

-

-

-

-

3

Total other income, net

518

-35

2,847

2,147

212

-92

Loss before income taxes

-3,045

-23,792

1,534

2,656

-21,573

18,066

Income tax expenses

2,653

1,319

-3,313

1,846

-1,576

5,892

Net loss

-5,698

-25,112

4,848

809

-19,997

12,173

Foreign currency translation adjustment

-2,753

-2,957

-208

-

546

2,007

Other comprehensive income

-

-

-

2,071

-

-

Comprehensive loss

-8,452

-28,070

4,639

2,880

-19,450

14,180

Net loss per share
Basic (in Dollars per share)

-2.50

-11.40

2.30

0.07

-

-

Diluted (in Dollars per share)

-2.50

-11.40

2.30

0.07

-

-

Weighted average number of common shares outstanding
Basic (in Shares)

2,297

2,210

2,071

11,510

-

-

Diluted (in Shares)

2,297

2,210

2,071

11,510

-

-

Net income (loss) per share Basic and diluted (in Dollars per share)

-

-

-

-

-2.09

1.31

Weighted average number of common shares outstanding Basic and diluted (in Shares)

-

-

-

-

9,570

9,298